Trials / Unknown
UnknownNCT04624685
iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 475 (estimated)
- Sponsor
- Glaukos Corporation · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Long term follow up of subjects in the IDE study for iStent Inject to monitor safety
Detailed description
To evaluate the long -term rate of clinically relevant complications associated with iStent inject® placement and stability in subjects who have completed participation of the IDE clinical trial (GC-008).
Conditions
Timeline
- Start date
- 2020-01-15
- Primary completion
- 2021-01-20
- Completion
- 2021-12-01
- First posted
- 2020-11-12
- Last updated
- 2021-10-20
Locations
24 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04624685. Inclusion in this directory is not an endorsement.